Problem statement: Answer the multiple-choice question.
Question: Which drug exhibits a -12.770% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any other words.
Options:
a O=C(COC(=O)CNC(=O)c1ccc(Cl)cc1Cl)NC(=O)NC1CCCCC1
b CCCC(=O)Nc1cccc(NC(=O)c2cccc([N+](=O)[O-])c2C)c1
c O=C(NNC(=O)c1cc2c(s1)CCCC2)c1ccccc1
Answer: b. CCCC(=O)Nc1cccc(NC(=O)c2cccc([N+](=O)[O-])c2C)c1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCCC(=O)Nc1cccc(NC(=O)c2cccc([N+](=O)[O-])c2C)c1
CCCC(=O)Nc1cccc(NC(=O)c2cccc([N+](=O)[O-])c2C)c1
N-[3-(butanoylamino)phenyl]-2-methyl-3-nitrobenzamide